Company Name: |
Tianjin Kailiqi Biotechnology Co., Ltd.
|
Tel: |
15076683720 |
Email: |
klq@cw-bio.com |
Products Intro: |
Product Name:nec-34 CAS:375835-43-1 Purity:≥98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
|
Company Name: |
ShangHai Biochempartner Co.,Ltd
|
Tel: |
17754423994 17754423994 |
Email: |
2853530910@QQ.com |
Products Intro: |
Product Name:Necrostatin-34 CAS:375835-43-1 Purity:98% HPLC LCMS Package:100MG;1G
|
|
| 2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4,5,6-tetrahydropyridin-2-yl]sulfanyl}-N-(1,3-thiazol-2-yl)acetamide Basic information |
Product Name: | 2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4,5,6-tetrahydropyridin-2-yl]sulfanyl}-N-(1,3-thiazol-2-yl)acetamide | Synonyms: | Necrostatin-34;nec-34;2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4,5,6-tetrahydropyridin-2-yl]sulfanyl}-N-(1,3-thiazol-2-yl)acetamide;2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4;2-((3-Cyano-6-oxo-4-(p-tolyl)-1,4,5,6-tetrahydropyridin-2-yl)thio)-N-(thiazol-2-yl)acetamide;Necrostatin 34,RIP kinase,FADD,Necrostatin-34,RIPK,inhibit,RIPK1,Receptor-interacting protein kinases,p-S166,Necroptosis,Necrostatin34,Inhibitor;Acetamide, 2-[[3-cyano-1,4,5,6-tetrahydro-4-(4-methylphenyl)-6-oxo-2-pyridinyl]thio]-N-2-thiazolyl- | CAS: | 375835-43-1 | MF: | C18H16N4O2S2 | MW: | 384.48 | EINECS: | | Product Categories: | | Mol File: | 375835-43-1.mol | ![2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4,5,6-tetrahydropyridin-2-yl]sulfanyl}-N-(1,3-thiazol-2-yl)acetamide Structure](CAS/20180629/GIF/375835-43-1.gif) |
| 2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4,5,6-tetrahydropyridin-2-yl]sulfanyl}-N-(1,3-thiazol-2-yl)acetamide Chemical Properties |
density | 1.41±0.1 g/cm3(Predicted) | storage temp. | 4°C, protect from light | solubility | DMSO : 125 mg/mL (325.11 mM; Need ultrasonic) | form | Solid | pka | 8.37±0.50(Predicted) | color | Off-white to light yellow |
| 2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4,5,6-tetrahydropyridin-2-yl]sulfanyl}-N-(1,3-thiazol-2-yl)acetamide Usage And Synthesis |
Biological Activity | Necrostatin-34 (Nec-34), a RIPK1 kinase inhibitor, stabilizes RIPK1 kinase in an inactive conformation by occupying a distinct binding pocket in the kinase domain[1].
Necrostatin-34 (Nec-34) exhibits IC50 values of 667 nM and 134 nM for TNFα in FADD def-Jurkat cells and L939 cells, respectively[1].Necrostatin-34 (Nec-34, 10 μM) inhibits the dimerization-induced RIPK1 activation as examined by phosphorylation of Ser166 (p-S166) of RIPK1, a biomarker for RIPK1 activation[1].Necrostatin-34 (Nec-34) may block TNFα-induced complex II formation by inhibiting the activation of RIPK1 kinase[1]. | References | [1]. Huyan Meng, et al. Discovery of a cooperative mode of inhibiting RIPK1 kinase. Cell Discov. 2021 Jun 1;7(1):41. |
| 2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4,5,6-tetrahydropyridin-2-yl]sulfanyl}-N-(1,3-thiazol-2-yl)acetamide Preparation Products And Raw materials |
|